at this stage people are pricing in disappointing results and applying a risk off strategy ie minimising risk for portfolio immunisation
its all good having some sort of heads of agreement with a brazilian distributor but until runs on the board ie $$ in bank ... we minimise risk
- Forums
- ASX - By Stock
- ALT
- Ann: App 4D and Half Year financial report
Ann: App 4D and Half Year financial report , page-5
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online